CA
IMNM icon

Clearstead Advisors’s Immunome IMNM Stock Holding History

Clearstead Advisors’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$85 Buy
+4
New +$86 ﹤0.01% 3394

Other funds holding IMNM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

Clearstead Advisors's IMNM Position: Q2 2026 in Review

Clearstead Advisors opened a new position in Immunome (IMNM) in Q2 2026: 4 shares worth $85. The stake represents ﹤0.01% of the portfolio and ranks #3394 among its holdings.

55 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Clearstead Advisors held 4 shares of Immunome worth $85 as of Q2 2026.
  • Immunome was a new Clearstead Advisors position in Q2 2026.
  • Immunome made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #3394 holding.
  • 55 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.